000			01606 a2200457 4500
005			20250514075446.0
264		0	_c20031215
008			200312s 0 0 eng d
022			_a1464-4096
024	7		_a10.1046/j.1464-410x.2003.04360.x _2doi
040			_aNLM _beng _cNLM
100	1		_aAli-El-Dein, B
245	0	0	_aSuperficial bladder tumours: analysis of prognostic factors and construction of a predictive index. _h[electronic resource]
260			_bBJU international _cSep 2003
300			_a393-9 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aBCG Vaccine _xadministration & dosage
650	0	4	_aCarcinoma, Transitional Cell _xdrug therapy
650	0	4	_aDisease Progression
650	0	4	_aDoxorubicin _xadministration & dosage
650	0	4	_aEpirubicin _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMultivariate Analysis
650	0	4	_aPredictive Value of Tests
650	0	4	_aProportional Hazards Models
650	0	4	_aTreatment Outcome
650	0	4	_aUrinary Bladder Neoplasms _xdrug therapy
700	1		_aSarhan, O
700	1		_aHinev, A
700	1		_aIbrahiem, El-H I
700	1		_aNabeeh, A
700	1		_aGhoneim, M A
773	0		_tBJU international _gvol. 92 _gno. 4 _gp. 393-9
856	4	0	_uhttps://doi.org/10.1046/j.1464-410x.2003.04360.x _zAvailable from publisher's website
999			_c12702099 _d12702099